Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001206333 | SCV001377636 | uncertain significance | Propionic acidemia | 2022-04-23 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 507 of the PCCA protein (p.Val507Met). This variant is present in population databases (rs146061036, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with PCCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 937344). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV004792792 | SCV005409625 | uncertain significance | not provided | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001206333 | SCV002094978 | uncertain significance | Propionic acidemia | 2021-04-20 | no assertion criteria provided | clinical testing |